Marcela V Maus

发表

Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection.

Eugene A Zhukovsky, Richard J Morse, Marcela V Maus, 2016, Current opinion in immunology.

Dynamic Profiling of Antitumor Activity of CAR T Cells Using Micropatterned Tumor Arrays

Mehmet Toner, Daniel Irimia, Marcela V Maus, 2019, Advanced science.

CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity

Marcela V Maus, William T Curry, Brian V Nahed, 2019, Nature Biotechnology.

Biomanufacturing for clinically advanced cell therapies

Marcela V Maus, David Smith, Daniel G Anderson, 2018, Nature Biomedical Engineering.

Enhancing T cell therapy through TCR signaling-responsive nanoparticle drug delivery

Li Tang, Na Li, Marcela V Maus, 2018, Nature Biotechnology.

Antibody-modified T cells: CARs take the front seat for hematologic malignancies.

Marcela V Maus, David L Porter, S. Grupp, 2014, Blood.

CD8+ T-cell responses to adeno-associated virus capsid in humans

Marcela V Maus, Hildegund C J Ertl, Haiyan Jiang, 2007, Nature Medicine.

A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes.

Marcela V Maus, James L Riley, C. June, 2002, Clinical immunology.

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.

Adam Bagg, Marcela V Maus, Bent K Jakobsen, 2013, Blood.